Global and United States Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2021-2027

Global and United States Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Limited Dilution Method
1.2.3 Micromanipulation
1.2.4 Soft Agar Plate Method
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biosimilar Monoclonal Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chronic & Autoimmune Diseases
1.3.3 Oncology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Monoclonal Antibody Market Perspective (2016-2027)
2.2 Biosimilar Monoclonal Antibody Growth Trends by Regions
2.2.1 Biosimilar Monoclonal Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biosimilar Monoclonal Antibody Historic Market Share by Regions (2016-2021)
2.2.3 Biosimilar Monoclonal Antibody Forecasted Market Size by Regions (2022-2027)
2.3 Biosimilar Monoclonal Antibody Industry Dynamic
2.3.1 Biosimilar Monoclonal Antibody Market Trends
2.3.2 Biosimilar Monoclonal Antibody Market Drivers
2.3.3 Biosimilar Monoclonal Antibody Market Challenges
2.3.4 Biosimilar Monoclonal Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue
3.1.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue (2016-2021)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2016-2021)
3.2 Global Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Monoclonal Antibody Revenue
3.4 Global Biosimilar Monoclonal Antibody Market Concentration Ratio
3.4.1 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibody Revenue in 2020
3.5 Biosimilar Monoclonal Antibody Key Players Head office and Area Served
3.6 Key Players Biosimilar Monoclonal Antibody Product Solution and Service
3.7 Date of Enter into Biosimilar Monoclonal Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Monoclonal Antibody Breakdown Data by Type
4.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Type (2016-2021)
4.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2022-2027)
5 Biosimilar Monoclonal Antibody Breakdown Data by Application
5.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Application (2016-2021)
5.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biosimilar Monoclonal Antibody Market Size (2016-2027)
6.2 North America Biosimilar Monoclonal Antibody Market Size by Type
6.2.1 North America Biosimilar Monoclonal Antibody Market Size by Type (2016-2021)
6.2.2 North America Biosimilar Monoclonal Antibody Market Size by Type (2022-2027)
6.2.3 North America Biosimilar Monoclonal Antibody Market Size by Type (2016-2027)
6.3 North America Biosimilar Monoclonal Antibody Market Size by Application
6.3.1 North America Biosimilar Monoclonal Antibody Market Size by Application (2016-2021)
6.3.2 North America Biosimilar Monoclonal Antibody Market Size by Application (2022-2027)
6.3.3 North America Biosimilar Monoclonal Antibody Market Size by Application (2016-2027)
6.4 North America Biosimilar Monoclonal Antibody Market Size by Country
6.4.1 North America Biosimilar Monoclonal Antibody Market Size by Country (2016-2021)
6.4.2 North America Biosimilar Monoclonal Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biosimilar Monoclonal Antibody Market Size (2016-2027)
7.2 Europe Biosimilar Monoclonal Antibody Market Size by Type
7.2.1 Europe Biosimilar Monoclonal Antibody Market Size by Type (2016-2021)
7.2.2 Europe Biosimilar Monoclonal Antibody Market Size by Type (2022-2027)
7.2.3 Europe Biosimilar Monoclonal Antibody Market Size by Type (2016-2027)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Application
7.3.1 Europe Biosimilar Monoclonal Antibody Market Size by Application (2016-2021)
7.3.2 Europe Biosimilar Monoclonal Antibody Market Size by Application (2022-2027)
7.3.3 Europe Biosimilar Monoclonal Antibody Market Size by Application (2016-2027)
7.4 Europe Biosimilar Monoclonal Antibody Market Size by Country
7.4.1 Europe Biosimilar Monoclonal Antibody Market Size by Country (2016-2021)
7.4.2 Europe Biosimilar Monoclonal Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Monoclonal Antibody Market Size (2016-2027)
8.2 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Type
8.2.1 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Application
8.3.1 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region
8.4.1 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosimilar Monoclonal Antibody Market Size (2016-2027)
9.2 Latin America Biosimilar Monoclonal Antibody Market Size by Type
9.2.1 Latin America Biosimilar Monoclonal Antibody Market Size by Type (2016-2021)
9.2.2 Latin America Biosimilar Monoclonal Antibody Market Size by Type (2022-2027)
9.2.3 Latin America Biosimilar Monoclonal Antibody Market Size by Type (2016-2027)
9.3 Latin America Biosimilar Monoclonal Antibody Market Size by Application
9.3.1 Latin America Biosimilar Monoclonal Antibody Market Size by Application (2016-2021)
9.3.2 Latin America Biosimilar Monoclonal Antibody Market Size by Application (2022-2027)
9.3.3 Latin America Biosimilar Monoclonal Antibody Market Size by Application (2016-2027)
9.4 Latin America Biosimilar Monoclonal Antibody Market Size by Country
9.4.1 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2016-2021)
9.4.2 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Monoclonal Antibody Market Size (2016-2027)
10.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type
10.2.1 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application
10.3.1 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country
10.4.1 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocon
11.1.1 Biocon Company Details
11.1.2 Biocon Business Overview
11.1.3 Biocon Biosimilar Monoclonal Antibody Introduction
11.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.1.5 Biocon Recent Development
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Details
11.2.2 Accord Healthcare Business Overview
11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Introduction
11.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.2.5 Accord Healthcare Recent Development
11.3 AET Biotech
11.3.1 AET Biotech Company Details
11.3.2 AET Biotech Business Overview
11.3.3 AET Biotech Biosimilar Monoclonal Antibody Introduction
11.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.3.5 AET Biotech Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Biosimilar Monoclonal Antibody Introduction
11.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Celltrion
11.5.1 Celltrion Company Details
11.5.2 Celltrion Business Overview
11.5.3 Celltrion Biosimilar Monoclonal Antibody Introduction
11.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.5.5 Celltrion Recent Development
11.6 Reddy's Laboratories
11.6.1 Reddy's Laboratories Company Details
11.6.2 Reddy's Laboratories Business Overview
11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Introduction
11.6.4 Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.6.5 Reddy's Laboratories Recent Development
11.7 Hospira
11.7.1 Hospira Company Details
11.7.2 Hospira Business Overview
11.7.3 Hospira Biosimilar Monoclonal Antibody Introduction
11.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.7.5 Hospira Recent Development
11.8 3SBio
11.8.1 3SBio Company Details
11.8.2 3SBio Business Overview
11.8.3 3SBio Biosimilar Monoclonal Antibody Introduction
11.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.8.5 3SBio Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Biosimilar Monoclonal Antibody Introduction
11.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.9.5 Allergan Recent Development
11.10 Alvartis
11.10.1 Alvartis Company Details
11.10.2 Alvartis Business Overview
11.10.3 Alvartis Biosimilar Monoclonal Antibody Introduction
11.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2016-2021)
11.10.5 Alvartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Limited Dilution Method
Table 3. Key Players of Micromanipulation
Table 4. Key Players of Soft Agar Plate Method
Table 5. Key Players of Others
Table 6. Global Biosimilar Monoclonal Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biosimilar Monoclonal Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Biosimilar Monoclonal Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Biosimilar Monoclonal Antibody Market Share by Regions (2016-2021)
Table 10. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Biosimilar Monoclonal Antibody Market Share by Regions (2022-2027)
Table 12. Biosimilar Monoclonal Antibody Market Trends
Table 13. Biosimilar Monoclonal Antibody Market Drivers
Table 14. Biosimilar Monoclonal Antibody Market Challenges
Table 15. Biosimilar Monoclonal Antibody Market Restraints
Table 16. Global Biosimilar Monoclonal Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Biosimilar Monoclonal Antibody Market Share by Players (2016-2021)
Table 18. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibody as of 2020)
Table 19. Ranking of Global Top Biosimilar Monoclonal Antibody Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Biosimilar Monoclonal Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biosimilar Monoclonal Antibody Product Solution and Service
Table 23. Date of Enter into Biosimilar Monoclonal Antibody Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Monoclonal Antibody Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2016-2021)
Table 27. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Biosimilar Monoclonal Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2016-2021)
Table 31. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Biosimilar Monoclonal Antibody Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Biosimilar Monoclonal Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Biosimilar Monoclonal Antibody Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Biosimilar Monoclonal Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Biosimilar Monoclonal Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Biosimilar Monoclonal Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Biosimilar Monoclonal Antibody Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Biosimilar Monoclonal Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Biosimilar Monoclonal Antibody Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Biosimilar Monoclonal Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Biosimilar Monoclonal Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Biosimilar Monoclonal Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Biosimilar Monoclonal Antibody Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Biosimilar Monoclonal Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Biosimilar Monoclonal Antibody Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Biosimilar Monoclonal Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 63. Biocon Company Details
Table 64. Biocon Business Overview
Table 65. Biocon Biosimilar Monoclonal Antibody Product
Table 66. Biocon Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 67. Biocon Recent Development
Table 68. Accord Healthcare Company Details
Table 69. Accord Healthcare Business Overview
Table 70. Accord Healthcare Biosimilar Monoclonal Antibody Product
Table 71. Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 72. Accord Healthcare Recent Development
Table 73. AET Biotech Company Details
Table 74. AET Biotech Business Overview
Table 75. AET Biotech Biosimilar Monoclonal Antibody Product
Table 76. AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 77. AET Biotech Recent Development
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Biosimilar Monoclonal Antibody Product
Table 81. Amgen Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 82. Amgen Recent Development
Table 83. Celltrion Company Details
Table 84. Celltrion Business Overview
Table 85. Celltrion Biosimilar Monoclonal Antibody Product
Table 86. Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 87. Celltrion Recent Development
Table 88. Reddy's Laboratories Company Details
Table 89. Reddy's Laboratories Business Overview
Table 90. Reddy's Laboratories Biosimilar Monoclonal Antibody Product
Table 91. Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 92. Reddy's Laboratories Recent Development
Table 93. Hospira Company Details
Table 94. Hospira Business Overview
Table 95. Hospira Biosimilar Monoclonal Antibody Product
Table 96. Hospira Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 97. Hospira Recent Development
Table 98. 3SBio Company Details
Table 99. 3SBio Business Overview
Table 100. 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 101. 3SBio Recent Development
Table 102. Allergan Company Details
Table 103. Allergan Business Overview
Table 104. Allergan Biosimilar Monoclonal Antibody Product
Table 105. Allergan Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 106. Allergan Recent Development
Table 107. Alvartis Company Details
Table 108. Alvartis Business Overview
Table 109. Alvartis Biosimilar Monoclonal Antibody Product
Table 110. Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2016-2021) & (US$ Million)
Table 111. Alvartis Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Monoclonal Antibody Market Share by Type: 2020 VS 2027
Figure 2. Limited Dilution Method Features
Figure 3. Micromanipulation Features
Figure 4. Soft Agar Plate Method Features
Figure 5. Others Features
Figure 6. Global Biosimilar Monoclonal Antibody Market Share by Application: 2020 VS 2027
Figure 7. Chronic & Autoimmune Diseases Case Studies
Figure 8. Oncology Case Studies
Figure 9. Others Case Studies
Figure 10. Biosimilar Monoclonal Antibody Report Years Considered
Figure 11. Global Biosimilar Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Biosimilar Monoclonal Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biosimilar Monoclonal Antibody Market Share by Regions: 2020 VS 2027
Figure 14. Global Biosimilar Monoclonal Antibody Market Share by Regions (2022-2027)
Figure 15. Global Biosimilar Monoclonal Antibody Market Share by Players in 2020
Figure 16. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibody as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Biosimilar Monoclonal Antibody Revenue in 2020
Figure 18. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2016-2021)
Figure 19. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2022-2027)
Figure 20. North America Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Biosimilar Monoclonal Antibody Market Share by Type (2016-2027)
Figure 22. North America Biosimilar Monoclonal Antibody Market Share by Application (2016-2027)
Figure 23. North America Biosimilar Monoclonal Antibody Market Share by Country (2016-2027)
Figure 24. United States Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Biosimilar Monoclonal Antibody Market Share by Type (2016-2027)
Figure 28. Europe Biosimilar Monoclonal Antibody Market Share by Application (2016-2027)
Figure 29. Europe Biosimilar Monoclonal Antibody Market Share by Country (2016-2027)
Figure 30. Germany Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Biosimilar Monoclonal Antibody Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Biosimilar Monoclonal Antibody Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Biosimilar Monoclonal Antibody Market Share by Region (2016-2027)
Figure 40. China Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Biosimilar Monoclonal Antibody Market Share by Type (2016-2027)
Figure 48. Latin America Biosimilar Monoclonal Antibody Market Share by Application (2016-2027)
Figure 49. Latin America Biosimilar Monoclonal Antibody Market Share by Country (2016-2027)
Figure 50. Mexico Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Biosimilar Monoclonal Antibody Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Biosimilar Monoclonal Antibody Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Biosimilar Monoclonal Antibody Market Share by Country (2016-2027)
Figure 56. Turkey Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Biosimilar Monoclonal Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biocon Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 60. Accord Healthcare Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 61. AET Biotech Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 63. Celltrion Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 64. Reddy's Laboratories Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 65. Hospira Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 66. 3SBio Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 67. Allergan Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 68. Alvartis Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs